Flowbone develops and promotes a biomaterial for the minimal-invasive augmentation of fragile bones at high risk of fracture.
Flowbone has raised €138k across 1 funding round, most recently a round in Nov 2020. Based in Renens, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-11-25 | Other | €138k |
| — |
| View deal → |
